Self-nano-emulsifying drug-delivery systems: From the development to the current applications and challenges in oral drug delivery
Approximately one third of newly discovered drug molecules show insufficient water
solubility and therefore low oral bio-availability. Self-nano-emulsifying drug-delivery systems …
solubility and therefore low oral bio-availability. Self-nano-emulsifying drug-delivery systems …
Smart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive review
This review focuses on the smart chemistry that has been utilized in developing polymer-
based drug delivery systems over the past 10 years. We provide a comprehensive overview …
based drug delivery systems over the past 10 years. We provide a comprehensive overview …
BCS class IV drugs: Highly notorious candidates for formulation development
BCS class IV drugs (eg, amphotericin B, furosemide, acetazolamide, ritonavir, paclitaxel)
exhibit many characteristics that are problematic for effective oral and per oral delivery …
exhibit many characteristics that are problematic for effective oral and per oral delivery …
Current approaches in lipid-based nanocarriers for oral drug delivery
M Plaza-Oliver, MJ Santander-Ortega… - Drug Delivery and …, 2021 - Springer
Lipid-based nanocarriers have gained much interest as carriers of drugs with poor oral
bioavailability because of their remarkable advantages like low toxicity, affordable scale-up …
bioavailability because of their remarkable advantages like low toxicity, affordable scale-up …
Solid self emulsifying drug delivery system: Superior mode for oral delivery of hydrophobic cargos
I Maji, S Mahajan, A Sriram, P Medtiya… - Journal of Controlled …, 2021 - Elsevier
A significant proportion of recently approved drug molecules possess poor aqueous
solubility which further restrains their desired bioavailability. Poor aqueous solubility of these …
solubility which further restrains their desired bioavailability. Poor aqueous solubility of these …
Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self‐emulsifying systems
Poorly water‐soluble drug candidates are becoming more prevalent. It has been estimated
that approximately 60–70% of the drug molecules are insufficiently soluble in aqueous …
that approximately 60–70% of the drug molecules are insufficiently soluble in aqueous …
Lipid based nanocarriers: a translational perspective
Over the recent couple of decades, pharmaceutical field has embarked most phenomenal
noteworthy achievements in the field of medications as well as drug delivery. The rise of …
noteworthy achievements in the field of medications as well as drug delivery. The rise of …
Nanoemulsion delivery systems for enhanced efficacy of antimicrobials and essential oils
The ever-growing threat of new and existing infectious diseases in combination with
antimicrobial resistance requires the need for innovative and effective forms of drug delivery …
antimicrobial resistance requires the need for innovative and effective forms of drug delivery …
Self-nanoemulsifying drug delivery system for pancreatic cancer
Pancreatic cancer is the world's fourth largest causative factor of mortality with a five year of
survival rate. Poor definitive diagnosis can be ascribed to both problematic early detections …
survival rate. Poor definitive diagnosis can be ascribed to both problematic early detections …
From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)
Introduction: Lipid-based drug delivery systems (LBDDS) are the most promising technique
to formulate the poorly water soluble drugs. Nanotechnology strongly influences the …
to formulate the poorly water soluble drugs. Nanotechnology strongly influences the …